DEDICATED TO TREATING PATIENTS

With Rare and Severe
Metabolic Diseases

UTILIZING THE GI TRACT

to Reduce the Burden
of Metabolic Disease

UNDERSTANDING

Metabolic Diseases
that Affect the Kidney

News

ALLENA PHARMACEUTICALS APPOINTS RICHARD D. KATZ, M.D. AS CHIEF FINANCIAL OFFICER

ALLENA PHARMACEUTICALS TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN JANUARY

ALLENA PHARMACEUTICALS INCREASES PREVIOUSLY ANNOUNCED BOUGHT DEAL TO $13.0 MILLION

Scroll to Top